JMP Securities Starts Crinetics (CRNX) at Market Outperform

JMP Securities analyst Jonathan Wolleben initiates coverage on Crinetics (NASDAQ: CRNX) with a Market Outperform rating and a price target of $43.00.

For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.

Shares of Crinetics closed at $23.90 yesterday.

You May Also Be Interested In

• H.C. Wainwright Reiterates Neutral Rating on Crinetics (CRNX)
• RBC Capital Starts Krystal Biotech (KRYS) at Outperform
• Raymond James Starts SpyGlass Pharma (SGP) at Outperform